Abiopharma

(70% Positive) AIxCrypto Holdings, Inc. (QLGN) Announces Business Combination

Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA Including More Than Two Years Median Overall Survival Benefit

Alvotech (ALVOW) Files Form 6-K

Inside the Smart India Hackathon: Innovation, Impact, and the Power of Youth in Problem-Solving

GENFIT: Favorable Phase 1 Safety Profile and Strong Anti-Inflammatory Activity for ACLF Lead Asset G1090N

📋 Guyer William (Officer) plans to sell 20K shares of CORCEPT THERAPEUTICS INC (at $34.95 each, total $699K) Filed: Jan 06, 2026 | ID: 000003

Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman

📋 Blanchfield Paul (Ex-Officer) plans to sell 7K shares of Lantheus Holdings, Inc. (at $69.53 each, total $502K) Filed: Jan 06, 2026 | ID: 000134

HALEON PLC (HLN) Files Form 6-K

VB Spine finalise le rachat à Stryker du site de fabrication de Cestas

📋 WAGNER CHARLES F JR (Officer) plans to sell 10K shares of VERTEX PHARMACEUTICALS INC / MA (at $461.00 each, total $4.4M) Filed: Jan 06, 2026 | ID: 000131

📋 Shlevin Harold H. (Director) plans to sell 442K shares of GALECTIN THERAPEUTICS INCORPORATED (at $4.16 each, total $1.8M) Filed: Jan 06, 2026 | ID: 000797

Acadia Healthcare to Participate in 44th Annual J.P. Morgan Healthcare Conference

Final approval of ANDA #ANDA #219053 for ACETAMINOPHEN; IBUPROFEN. Decision date: 01/02/2026

New Form 25-NSE - CureVac N.V. Filed: 2026-01-06 AccNo: 0001354457-26-000010 Size: 3 KB